Allogene Therapeutics Inc (NASDAQ: ALLO) established initial surge of 7.69% at $3.22, before settling in for the price of $2.99 at the close. Taking a
On Friday, Allogene Therapeutics Inc (NASDAQ: ALLO) was 6.46% up from the session before settling in for the closing price of $2.56. A 52-week range
Allogene Therapeutics Inc (NASDAQ: ALLO) started the day on Wednesday, with a price decrease of -5.71% at $2.64, before settling in for the price of
A new trading day began on Friday, with Allogene Therapeutics Inc (NASDAQ: ALLO) stock price down -3.94% from the previous day of trading, before settling
Allogene Therapeutics Inc (NASDAQ: ALLO) flaunted slowness of -5.61% at $2.69, before settling in for the price of $2.85 at the close. Taking a more
Allogene Therapeutics Inc (NASDAQ: ALLO) kicked off on Monday, down -0.75% from the previous trading day, before settling in for the closing price of $2.65.
Allogene Therapeutics Inc (NASDAQ: ALLO) kicked off on Tuesday, up 6.20% from the previous trading day, before settling in for the closing price of $2.58.
As on Thursday, Allogene Therapeutics Inc (NASDAQ: ALLO) got off with the flyer as it spiked 3.16% to $2.61, before settling in for the price
Allogene Therapeutics Inc (NASDAQ: ALLO) kicked off on Monday, down -3.78% from the previous trading day, before settling in for the closing price of $2.91.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
